# Fibrotic Focus in Breast Cancer

> **NCT04122131** · — · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 250 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Immunohistochemistry

## Key facts

- **NCT ID:** NCT04122131
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-01
- **Primary completion:** 2022-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2019-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04122131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04122131, "Fibrotic Focus in Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04122131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*